11ÔÂ28ÈÕ£¬¹ú¼ÒÒ½ÁÆ°ü¹Ü¾Ö¡¢ÈËÁ¦×ÊÔ´ºÍÉç»á°ü¹Ü²¿ÕýʽÐû²¼ÁË¡¶¹ú¼Ò»ù±¾Ò½ÁÆ°ü¹Ü¡¢¹¤ÉË°ü¹ÜºÍÉúÓý°ü¹ÜҩƷĿ¼(2024Äê)¡·¡£ÊæËÙ´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ¾­Ì¸ÅÐÊ״α»ÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼¡£Ð°æĿ¼½«ÓÚ2025Äê1ÔÂ1ÈÕÕýʽʵÑé¡£

ÊæËÙ´ï^®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ

       ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÊô±´ÌØÀàѪ֬µ÷ÀíÒ©£¬Í¨¹ýÒÖÖƼ«µÍÃܶÈÖ¬ÂÑ°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄÌìÉú²¢Í¬Ê±Ê¹ÆäÆÊÎö´úлÔö¶à£¬½µµÍѪµÍÃܶÈÖ¬ÂÑ°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥£»»¹Ê¹ÔØÖ¬ÂÑ°×A1ºÍA11ÌìÉúÔöÌí£¬´Ó¶øÔö¸ß¸ßÃܶÈÖ¬ÂÑ°×µ¨¹Ì´¼¡£ÊæËÙ´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÓÅ»¯µ¨¼îÑνṹ£¬¾ßÓнϺõÄË®ÈÜÐÔ£¬ÏÔÖøÌáÉýÁËÉúÎïʹÓöÈ^[1]£»Ò»´ÎÒ»Á££¨135mg£©,Ò»ÌìÒ»´Î£¬ÎÞÐèÓë²Íͬ·þ£¬ÌáÉýÓÃÒ©±ãµ±ÐÔ^[2]¡£¿ÉÖ±½ÓÔÚÌåÄÚÊ©Õ¹×÷Óã¬ÎÞÐè¾­ÓɸÎÔàÊ×¹ý´úл£¬´Ó¶ø¿É½µµÍ¸ÎÔà¼ç¸º^[1]¡£ËµÃ÷ÊéÖ¸³ö£¬±¾Æ·ÓëËûÍ¡ÀàÒ©ÎïÍŽáʹÓÃÎÞÐèµ÷½â±¾Æ·»òÊÊÓÃÒ©ÎïµÄ¼ÁÁ¿¡£

ºÏ×÷×ÉѯÈÈÏß:4001833668

¿ÉɨÂë¹ÒºÅºÏ×÷ÐÅÏ¢

²Î¿¼×ÊÁÏ£º

[1]     Elisavet Moutzouri ,Anastazia Kei,Moses S elisaf ,Haralampos J Milionis.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.Vascular Health and Risk Management 2010:6 525–539.

[2]   ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ˵Ã÷Êé.